Observational study of endocrine disorders and their effects
Official title: The Evaluation and Management of Endocrine-Related Conditions and Physiology
Run by National Institutes of Health Clinical Center (CC) · NCT03867448 · Data updated 2026-11-12
This study looks at adults with different hormone-related disorders to better understand their conditions and improve care for them.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Drugs / interventions | Radiation |
| Locations | 1 site (Bethesda, Maryland) |
| Status | Recruiting |
| Started | March 27, 2019 |
| Main results expected | January 1, 2036 |
| Study ends | January 1, 2036 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT03867448 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with diagnosed endocrine or metabolic-related disorders.
✕Probably not a fit
Patients with unstable conditions or severe organ failure may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate adults with various endocrine disorders to enhance understanding and education regarding these conditions. Participants will undergo a thorough screening process, including medical history reviews, physical exams, and various tests such as blood and urine analyses, imaging studies, and sample collections. The data gathered will be used for future research and to improve clinical practices in endocrinology. The study will also provide standard clinical care for participants based on their specific conditions.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and management of endocrine disorders.
How similar studies have gone: Other studies focusing on endocrine disorders have shown promise in improving understanding and treatment approaches, indicating that this study builds on established research.
Who can join: the full rules
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all the following criteria: * Adult men and women age 18 years or older. * Known or suspected endocrine disorders requiring clinical screening, management and/or treatment and follow-up. * Stated willingness to comply with all study procedures and availability for the duration of the study EXCLUSION CRITERIA: * Unstable participants and participants with severe organ failure, or those with a condition or medical treatment that may affect/limit the endocrine work-up and exhaust Clinical Center, IETP resources will be excluded if appropriate. * Inability of a subject to adhere to a proposed schedule of visits. * Inability to provide informed consent.
Where it's running
-
National Institutes of Health Clinical Center
Bethesda, Maryland, United States Recruiting
Study contacts
- Principal investigator: Lynnette K Nieman, M.D. — National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Study coordinator: Raven N McGlotten, R.N.
- Email: mcglottenr@mail.nih.gov
- Phone: (301) 827-0190
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Male Hypogonadism: How Stigma and Identity relate to Quality of Life
This study tests whether men with hypogonadism feel more anticipated stigma and have a different illness identity compared with men with other chronic endocrine conditions, and whether those psychosocial factors predict quality of life.
-
Environmental and inflammatory links to metabolic and endocrine diseases
This project will see if combining environmental, genetic, and protein information can help predict early risk of diabetes, hypertension, and other metabolic or endocrine problems in community adults.
-
Steroid blood‑profile score to help diagnose mild autonomous cortisol‑secreting adrenal nodules (MACS)
This study will test if a single blood test measuring 19 steroid hormones plus basic clinical measures can distinguish people with mild autonomous cortisol secretion (MACS) from those with non‑secreting adrenal adenomas.
-
Collecting data on thyroid, parathyroid, and adrenal diseases
This study is collecting health information from people with thyroid, parathyroid, and adrenal diseases to see how these conditions affect them over time.
-
Improving diagnosis and treatment of pheochromocytoma
This study is testing new ways to find and treat pheochromocytomas, which are tumors from the adrenal glands, to help improve care for people with this condition.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.